
# ZAAWANSOWANY SZKIELET MANUSKRYPTU (OPARTY NA DOWODACH)
# ==========================================================

# **Tytuł:** Reconciling Efficacy and Sleep in Adult ADHD: A Clinician's Guide to the Chronopharmacology of Stimulants and Melatoninergics

---
### **1. Wprowadzenie (Introduction)**
---
- **1.1. The Clinical Challenge: ADHD and Sleep Disturbance in Adults.**
- **Key Evidence:** [PMID: 23509113 (JAR, 2017); PMID: 24117273 (JAR, 2013); PMID: 35246824 (JAR, 2022); PMID: 31248601 (CDCJAPG, 2019)]
- **Prompts for Synthesis:**
  - *Review paper [PMID: 23509113]: What is the core argument or finding presented?*
  - *Review paper [PMID: 24117273]: What is the core argument or finding presented?*
  - *Review paper [PMID: 35246824]: What is the core argument or finding presented?*
  - *Review paper [PMID: 31248601]: What is the core argument or finding presented?*

- **1.2. The Stimulant Paradox: Therapeutic Agent and Potential Sleep Disruptor.**
- **Key Evidence:** [PMID: 35635014 (CTJA, 2023); PMID: 24224626 (JAR, 2013); PMID: 26905919 (JARCTRSNG, 2016); PMID: 23216449 (JAR, 2014)]
- **Prompts for Synthesis:**
  - *Analyze RCT [PMID: 35635014]: What were the primary outcomes, intervention details, and study population?*
  - *Review paper [PMID: 24224626]: What is the core argument or finding presented?*
  - *Analyze RCT [PMID: 26905919]: What were the primary outcomes, intervention details, and study population?*
  - *Review paper [PMID: 23216449]: What is the core argument or finding presented?*

- **1.3. Objective:** To provide an evidence-based, clinical guide for an integrated chronopharmacological approach.

---
### **2. Metody (Methods)**
---
- **2.1. Literature Search and Selection Strategy.**
  - *Zadanie: Opisać proces (Etapy 1-7) na podstawie pliku `methods_narrative.md`.*
  - *Powołać się na załącznik `query_appendix.md`.*
- **Key Evidence:** [PMID: 23672818 (CSJARCTRSNG, 2013); PMID: 19281939 (JARSNERSNGR, 2009)]
- **Prompts for Synthesis:**
  - *Analyze RCT [PMID: 23672818]: What were the primary outcomes, intervention details, and study population?*
  - *Review paper [PMID: 19281939]: What is the core argument or finding presented?*

---
### **3. Synteza Dowodów i Zastosowanie Kliniczne**
---
- **3.1. The Role of Stimulants as a Chronotherapeutic Intervention.**
- **Key Evidence:** [PMID: 35635014 (CTJA, 2023); PMID: 24224626 (JAR, 2013); PMID: 26905919 (JARCTRSNG, 2016); PMID: 23216449 (JAR, 2014)]
- **Prompts for Synthesis:**
  - *Analyze RCT [PMID: 35635014]: What were the primary outcomes, intervention details, and study population?*
  - *Review paper [PMID: 24224626]: What is the core argument or finding presented?*
  - *Analyze RCT [PMID: 26905919]: What were the primary outcomes, intervention details, and study population?*
  - *Review paper [PMID: 23216449]: What is the core argument or finding presented?*

- **3.2. The Role of Melatoninergic Interventions as Primary and Adjunctive Therapy.**
- *Brak bezpośrednich dowodów w korpusie do automatycznego mapowania.*

- **3.3. Clinical Algorithm for Integrated Management.**
  - *Zadanie: Na podstawie syntezy z pkt 3.1 i 3.2, stwórz graficzny lub opisowy algorytm decyzyjny dla klinicysty.*

---
### **4. Wnioski (Conclusion)**
---
- **4.1. Key Recommendations for Clinical Practice.**
- **4.2. Identified Gaps and Future Research Directions.**

